# What do blood and marrow treatments involve? *Blood and Marrow Preparations — Joint Injections Queen Creek* > For a PRP injection knee visit, blood is spun and a small share is used. Compare blood and marrow choices for joint injections Queen Creek care. Give the joint an easier day when hard use brings on soreness. Shorten the walk, but keep some comfortable movement. That'll help while you decide whether a visit is worthwhile. Blood and marrow treatments both start with something taken from your body. They aren't collected or prepared in the same way. ## What does PRP stand for? When you see PRP, it means platelet-rich plasma. The clinic draws your blood and spins it in a machine. A small part remains with more platelets, tiny blood parts involved in clotting and healing. Concentrated PRP simply has more of them than usual blood. The shot is offered in hopes of easing soreness, though relief isn't certain. ## How is marrow treatment different? Marrow is drawn from bone, often near the pelvis. That can leave another sore spot and makes the visit more involved. The sample is spun so some fluid is separated. What remains is a smaller mix of marrow and blood for the shot. You'll want details about the collection spot and soreness afterward. ## Which preparation details matter? Clinics may spin blood at different speeds or keep different amounts. Ask what remains in the shot and what was removed. For marrow, ask where it's drawn and how the spot may feel later. The answer should name the actual material, not only some letters. Then track sleep, walking or rising from a chair after the visit. ## What if rest and lighter use aren't enough? When lighter use isn't enough, QC Kinetix offers regenerative treatments, or non-surgical care made with your blood or marrow at the clinic. It's offered to ease soreness and help keep your joint working. Medical providers are the licensed staff who examine the joint. You'll get answers even if you decide against treatment. ## Sources 1. A systematic review of 105 clinical orthopaedic PRP studies found only 11 (10%) described the preparation protocol well enough to be repeated, and only 17 (16%) reported quantitative metrics on the composition of the final PRP product - so 'PRP' in one trial is frequently not the same product as 'PRP' in another. Chahla J, et al. — [A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature.](https://pubmed.ncbi.nlm.nih.gov/29040132/). *J Bone Joint Surg Am*, 2017. DOI: 10.2106/JBJS.16.01374. 2. A meta-analysis of 18 level-I studies (1,608 patients) found greater mean WOMAC improvement with PRP (44.7%) than hyaluronic acid (12.6%), and found leukocyte-POOR PRP associated with significantly better subjective IKDC scores than leukocyte-rich PRP. Belk JW, et al. — [Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.](https://pubmed.ncbi.nlm.nih.gov/32302218/). *Am J Sports Med*, 2021. DOI: 10.1177/0363546520909397. 3. A double-blind randomized trial directly comparing leukocyte-rich with leukocyte-poor PRP (3 injections each) found NO difference in clinical scores at any follow-up to 12 months (IKDC 45.6 to 60.7 versus 46.8 to 62.9), contradicting the meta-analytic signal favouring leukocyte-poor preparations. Di Martino A, et al. — [Leukocyte-Rich versus Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis: A Double-Blind Randomized Trial.](https://pubmed.ncbi.nlm.nih.gov/35103547/). *Am J Sports Med*, 2022. DOI: 10.1177/03635465211064303. 4. A 2025 EFORT Open Reviews synthesis of evidence-based orthobiologics guidance notes that meta-analyses report PRP improving patient-reported outcomes in knee osteoarthritis, lateral epicondylitis and plantar fasciitis, but that the underlying RCTs frequently carry a high risk of bias driven by heterogeneous preparation protocols and inconsistent trial quality. Winkler T, et al. — [Evidence-based guidelines on orthobiologics.](https://pubmed.ncbi.nlm.nih.gov/40459170/). *EFORT Open Rev*, 2025. DOI: 10.1530/EOR-2025-0069. 5. The RESTORE randomized trial (288 participants, leukocyte-poor PRP, 3 weekly injections) found no significant difference from saline placebo at 12 months in knee pain (-2.1 vs -1.8 points; difference -0.4, 95% CI -0.9 to 0.2) or in medial tibial cartilage volume (-1.4% vs -1.2%), with 29 of 31 secondary outcomes also showing no between-group difference. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 6. The 2025 Cochrane living review of stem cell injections for knee OA (25 trials, 1,341 participants) found stem cell injection MAY slightly improve pain and function up to six months versus placebo (pain 1.2 points better on a 0-10 scale; function 14.2 points better on 0-100), but rated the evidence LOW certainty for both, downgraded for indirectness and suspected publication bias, with up to three larger RCTs withdrawn before reporting results. Whittle SL, et al. — [Stem cell injections for osteoarthritis of the knee.](https://pubmed.ncbi.nlm.nih.gov/40169165/). *Cochrane Database Syst Rev*, 2025. DOI: 10.1002/14651858.CD013342.pub2. 7. FDA's HCT/P guidance sets out the minimal-manipulation and homologous-use criteria that decide whether a human cell or tissue product is regulated solely under 21 CFR Part 1271 (section 361) or requires a biologics licence; cell-based orthopaedic injections that fall outside those criteria are unapproved drugs and biological products, and no cell-based product is FDA-approved to treat osteoarthritis. U.S. Food and Drug Administration — [Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use - Guidance for Industry and FDA Staff](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal). *U.S. Food and Drug Administration*, 2020. ## What is worth taking to a joint visit? Note when the soreness began and which motion starts it. Take your medicine list and an older scan report if you have one. You'll have an easier talk when those details are close at hand. The nearest listed location is in Chandler near the Loop 202 Dobson Road interchange. Call (602) 837-PAIN to confirm the address and visit details. Book a free consultation: --- Straight help for a sore joint. Plain help with joint injections queen creek residents may weigh for soreness, home care and nearby treatment choices. A plain Queen Creek guide for everyday joint aches and local care. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Chandler location recommended here. © 2026 The Queen Creek Joint Ledger. General health education only; a licensed clinician should evaluate your own joint.